Analysis of HER2 gene amplification using Differential PCR in breast cancer patients of Isfahan Province
Background: Amplification of HER2 is seen in 20-30% of breast cancer cases. Measurement of HER2 gene amplification appears to be of vital importance in planning the treatment schedule for patients with breast carcinoma. The aim of our study was to evaluate HER2 amplification status in malignant and...
Main Authors: | Zohreh Hojati, Zeinab Hallajian, Abolghasem Esmaeili, Majid Motovali-Bashi, Hosein Tabatabaeian |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences and Health Services
2014-10-01
|
Series: | Research in Molecular Medicine |
Subjects: | |
Online Access: | http://rmm.mazums.ac.ir/browse.php?a_code=A-10-615-8&slc_lang=en&sid=1 |
Similar Items
-
Optimization of Real Time PCR for Precise Measurement of HER2 Overexpression in Breast Cancer Specimens
by: Samira Sadeghi, et al.
Published: (2015-04-01) -
A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer
by: Ignacio Juarez, et al.
Published: (2021-06-01) -
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer
by: Xiuwen Guan, et al.
Published: (2020-02-01) -
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
by: Zhou L, et al.
Published: (2019-07-01) -
Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification
by: Ye Hong, et al.
Published: (2021-02-01)